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I. Materials and Methods 
Unless otherwise noted, all chemicals and reagents for chemical reactions were 
obtained from commercial suppliers (Acros, Arch Bioscience, Fisher Scientific, Sigma-
Aldrich, TCI America) and used without further purification. The following proteins 
were all purchased from Sigma-Aldrich: bovine serum albumin (BSA), cytochrome c 
(from bovine, equine heart and S. cerevisiae), peroxidase II (from horseradish), and 
catalase (from C. glutamicum). Silica gel chromatography purifications were carried out 
using AMD Silica Gel 60, 230-400 mesh. 1H and 13C NMR spectra were recorded on a 
Bruker Prodigy 400 MHz instrument and are internally referenced to the residual solvent 
peak (chloroform). 29Si NMR spectra were recorded on the same instrument and 
referenced to tetramethoxysilane (δ −78.9 ppm). Data for 1H NMR are reported in the 
conventional form: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, hept = heptet, m = multiplet, br = broad, app = appears as), coupling 
constant (Hz), integration. Data for 13C and 29Si are reported in terms of chemical shift (δ 
ppm). High-resolution mass spectra were obtained with a JEOL JMS-600H High 
Resolution Mass Spectrometer at the California Institute of Technology Mass Spectral 
Facility. Sonication was performed using a Qsonica Q500 sonicator. Chemical reactions 
were monitored using thin layer chromatography (Merck 60 silica gel plates) and a UV-
lamp for visualization. Gas chromatography (GC) analyses were carried out using a 
Shimadzu GC-17A gas chromatograph, a FID detector, and J&W HP-5 (30 m x 0.32 mm, 
0.25 μm film; 90 °C hold 1 min, 90 to 110 °C at 15 °C/min, 110 to 280 °C at 60 °C/min, 
280 °C hold 1 min, 6.2 min total). Analytical chiral supercritical fluid chromatography 
(SFC) was performed with a JACSO 2000 series instrument using i-PrOH and 
supercritical CO2 as the mobile phase, with visualization at 210 nm. The following chiral 
columns were used: Daicel Chiralpak IC, Chiralpak AD-H, or Chiralcel OD-H (4.6 mm x 
25 cm). 
Plasmid pET22 was used as a cloning vector, and cloning was performed using 
Gibson assembly (31). The cytochrome c maturation plasmid pEC86 (32) was used as 
part of a two-plasmid system to express prokaryotic cytochrome c proteins. Cells were 
grown using Luria-Bertani medium or HyperBroth (AthenaES) with 100 μg/mL 
ampicillin and 20 μg/mL chloramphenicol (LBamp/chlor or HBamp/chlor). Cells without the 
pEC86 plasmid were grown with 100 μg/mL ampicillin (LBamp or HBamp). Primer 
sequences are available upon request. Electrocompetent Escherichia coli cells were 
prepared following the protocol of Sambrook et al. (33). T5 exonuclease, Phusion 
polymerase, and Taq ligase were purchased from New England Biolabs (NEB, Ipswich, 
MA). M9-N minimal medium (abbreviated as M9-N buffer; pH 7.4) was used as a 
buffering system for whole cells, lysates, and purified proteins, unless otherwise 
specified. M9-N buffer was used without a carbon source; it contains 47.7 mM Na2HPO4, 
22.0 mM KH2PO4, 8.6 mM NaCl, 2.0 mM MgSO4, and 0.1 mM CaCl2. 
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II. General Procedures  
 
(A) Plasmid construction.   All variants described in this paper were cloned and 
expressed using the pET22(b)+ vector (Novagen). The gene encoding Rma cyt c 
(UNIPROT ID B3FQS5) was obtained as a single gBlock (IDT), codon-optimized for E. 
coli, and cloned using Gibson assembly (31) into pET22(b)+ (Novagen) between 
restriction sites NdeI and XhoI in frame with an N-terminal pelB leader sequence (to 
ensure periplasmic localization and proper maturation; MKYLLPTAAAGLLLLAAQPA 
MA) and a C-terminal 6xHis-tag. This plasmid was co-transformed with the cytochrome 
c maturation plasmid pEC86 (32) into E. cloni® EXPRESS BL21(DE3) cells (Lucigen). 
 
(B) Cytochrome c expression and purification.   Purified cytochrome c proteins 
were prepared as follows. One liter HBamp/chlor in a 4 L flask was inoculated with an 
overnight culture (20 mL, LBamp/chlor) of recombinant E. cloni® EXPRESS BL21(DE3) 
cells containing a pET22(b)+ plasmid encoding the cytochrome c variant, and the pEC86 
plasmid. The culture was shaken at 37 °C and 200 rpm (no humidity control) until the 
OD600 was 0.7 (approximately 3 hours). The culture was placed on ice for 30 minutes, and 
isopropyl β-D-1-thiogalactopyranoside (IPTG) and 5-aminolevulinic acid (ALA) were 
added to final concentrations of 20 μM and 200 μM respectively. 
The incubator temperature was reduced to 20 °C, and the culture was allowed to 
shake for 20 hours at 200 rpm. Cells were harvested by centrifugation (4 °C, 15 min, 
4,000xg), and the cell pellet was stored at −20 °C until further use (at least 24 hours). The 
cell pellet was resuspended in buffer containing 100 mM NaCl, 20 mM imidazole, and 20 
mM Tris-HCl buffer (pH 7.5 at 25 °C) and cells were lysed by sonication (2 minutes, 2 
seconds on, 2 seconds off, 40% duty cycle; Qsonica Q500 sonicator). Cell lysate was 
placed in a 75 °C heat bath for 10 minutes, and cell debris was removed by centrifugation 
for 20 min (5000xg, 4 °C). Supernatant was sterile filtered through a 0.45 μm cellulose 
acetate filter and purified using a 1 mL Ni-NTA column (HisTrap HP, GE Healthcare, 
Piscataway, NJ) using an AKTA purifier FPLC system (GE healthcare). The cytochrome 
c protein was eluted from the column by running a gradient from 20 to 500 mM 
imidazole over 10 column volumes. 
The purity of the collected cytochrome c fractions was analyzed using sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Pure fractions were 
pooled and concentrated using a 3 kDa molecular weight cut-off centrifugal filter and 
dialyzed overnight into 0.05 M phosphate buffer (pH = 7.5) using 3 kDa molecular 
weight cut-off dialysis tubing. The dialyzed protein was concentrated again, flash-frozen 
on dry ice, and stored at −20 °C.  
The concentration of cytochrome c was determined in triplicate using the ferrous 
assay described in section (E). 
 
(C) P450 and globin expression and purification.   Purified P450s and globins 
were prepared differently from the cytochrome c proteins, and described as follows. One 
liter HBamp in a 4 L flask was inoculated with an overnight culture (20 mL, LBamp) of 
recombinant E. cloni® EXPRESS BL21(DE3) cells containing a pET22(b)+ plasmid 
encoding the P450 or globin variant. The culture was shaken at 37 °C and 200 rpm (no 
humidity control) until the OD600 was 0.7 (approximately 3 hours). The culture was 
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placed on ice for 30 minutes, and IPTG and 5-ALA were added to final concentrations of 
0.5 mM and 1 mM, respectively. The incubator temperature was reduced to 20 °C, and 
the culture was allowed to shake for 20 hours at 200 rpm. Cells were harvested by 
centrifugation (4 °C, 15 min, 4,000xg), and the cell pellet was stored at −20 °C until 
further use (at least 24 hours). The cell pellet was resuspended in buffer containing 100 
mM NaCl, 20 mM imidazole, and 20 mM Tris-HCl buffer (pH 7.5 at 25 °C). Hemin (30 
mg/mL, 0.1 M NaOH; Frontier Scientific) was added to the resuspended cells such that 1 
mg of hemin was added for every 1 gram of cell pellet. Cells were lysed by sonication (2 
minutes, 1 seconds on, 2 seconds off, 40% duty cycle; Qsonica Q500 sonicator). Cell 
debris was removed by centrifugation for 20 min (27,000xg, 4 °C). Supernatant was 
sterile filtered through a 0.45 μm cellulose acetate filter, and purified using a 1 mL Ni-
NTA column (HisTrap HP, GE Healthcare, Piscataway, NJ) using an AKTA purifier 
FPLC system (GE healthcare). The P450 and globin proteins were eluted from the 
column by running a gradient from 20 to 500 mM imidazole over 10 column volumes.  
The purity of the collected protein fractions was analyzed using SDS-PAGE. Pure 
fractions were pooled and concentrated using a 10 kDa molecular weight cut-off 
centrifugal filter and buffer-exchanged with 0.1 M phosphate buffer (pH = 8.0). The 
purified protein was flash-frozen on dry ice and stored at −20 °C.  
P450 and globin concentrations were determined in triplicate using the hemochrome 
assay described in section (D). 
 
(D) Hemochrome assay.   A solution of sodium dithionite (10 mg/mL) was 
prepared in M9-N buffer. Separately, a solution of 1 M NaOH (0.4 mL) was mixed with 
pyridine (1 mL), followed by centrifugation (10,000xg, 30 seconds) to separate the 
excess aqueous layer gave a pyridine-NaOH solution. To a cuvette containing 700 μL 
protein solution (purified protein or heat-treated lysate) in M9-N buffer, 50 μL of 
dithionite solution and 250 μL pyridine-NaOH solution were added. The cuvette was 
sealed with Parafilm, and the UV-Vis spectrum was recorded immediately. Cytochrome c 
concentration was determined using ε550-535 = 22.1 mM-1cm-1 (34). Protein concentrations 
determined by the hemochrome assay were in agreement with that determined by the 
bicinchoninic acid (BCA) assay (Thermo Fisher) using bovine serum albumin (BSA) for 
standard curve preparation.  
 
(E) Ferrous assay.   To a cuvette containing 700 μL protein solution in M9-N 
buffer was added 50 μL of dithionite solution (10 mg/mL in M9-N buffer). The cuvette 
was sealed with Parafilm, and the UV-Vis spectrum was recorded immediately. The 
absorbance value for the peak at 550 nm was recorded, and background absorbance at 
600 nm was subtracted. Using the protein concentration as determined by the 
hemochrome assay, ferrous ε550-600 was determined to be 27 mM-1cm-1 for wild-type Rma 
cyt c, and 21 mM-1cm-1 for Rma V75T M100D M103E (see calibration curves shown on 
the following page). Concentrations of Rma M100D and V75T M100D were determined 
using the extinction coefficient calculated for V75T M100D M103E.  
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(F) Library construction.   Cytochrome c site-saturation mutagenesis libraries were 
generated using a modified version of the 22-codon site-saturation method (35). For each 
site-saturation library, oligonucleotides were ordered such that the coding strand 
contained the degenerate codon NDT, VHG or TGG. The reverse complements of these 
primers were also ordered. The three forward primers were mixed together in a 12:9:1 
ratio, (NDT:VHG:TGG) and the three reverse primers were mixed similarly. Two PCRs 
were performed, pairing the mixture of forward primers with a pET22(b)+ internal 
reverse primer, and the mixture of reverse primers with a pET22b internal forward 
primer. The two PCR products were gel purified, ligated together using Gibson assembly 
(31), and transformed into E. cloni® EXPRESS BL21(DE3) cells. Primer sequences are 
available upon request. 
 
(G) Enzyme library screening.   Single colonies were picked with toothpicks off of 
LBamp/chlor agar plates, and grown in deep-well (2 mL) 96-well plates containing LBamp/chlor 
(400 μL) at 37 °C, 250 rpm shaking, and 80% relative humidity overnight. After 16 
hours, 30 μL aliquots of these overnight cultures were transferred to deep-well 96-well 
plates containing HBamp/chlor (1 mL) using a 12-channel EDP3-Plus 5-50 μL pipette 
(Rainin). Glycerol stocks of the libraries were prepared by mixing cells in LBamp/chlor (100 
μL) with 50% v/v glycerol (100 μL). Glycerol stocks were stored at −78 °C in 96-well 
microplates. Growth plates were allowed to shake for 3 hours at 37 °C, 250 rpm shaking, 
and 80% relative humidity. The plates were then placed on ice for 30 min. Cultures were 
 
 
6 
 
induced by adding 10 μL of a solution, prepared in sterile deionized water, containing 2 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and 20 mM ALA. The incubator 
temperature was reduced to 20 °C, and the induced cultures were allowed to shake for 20 
hours (250 rpm, no humidity control). Cells were pelleted (4,000xg, 5 min, 4 °C) and 
resuspended in 500 μL M9-N buffer. For cell lysis, plates were placed in a 75 °C water 
bath for 10 min, followed by centrifugation (4,000xg, 5 min, 4 °C) to remove cell debris. 
The resulting heat-treated lysates (340 μL) were then transferred to deep-well plates for 
biocatalytic reactions. In an anaerobic chamber, to deep-well plates of heat-treated lysates 
were added Na2S2O4 (40 μL per well, 100 mM in dH2O), PhMe2SiH (10 μL per well, 400 
mM in MeCN) and Me-EDA (10 μL per well, 400 mM in MeCN). The plates were sealed 
with aluminum sealing tape, removed from the anaerobic chamber, and shaken at 400 
rpm for 1.5 h. After quenching with cyclohexane (1 mL), internal standard was added (20 
μL of 20 mM methyl 2-phenylacetate in cyclohexane) and the reaction mixtures were 
pipetted up and down to thoroughly mix the organic and aqueous layers. The plates were 
centrifuged (4,000xg, 5 min) and the organic layer (400 μL) was transferred to shallow-
well 96-well plates for SFC analysis. Hits from library screening were confirmed by 
small-scale biocatalytic reactions, which were analyzed by GC and SFC for accurate 
determination of turnovers and enantioselectivities. 
 
(H) Protein lysate preparation.   Protein lysates for biocatalytic reactions were 
prepared as follow: E. coli cells expressing Rma cyt c variant were pelleted (4,000xg, 5 
min, 4 °C), resuspended in M9-N buffer and adjusted to the appropriate OD600. The 
whole-cell solution was heat-treated (75 °C for 10 min) then centrifuged (14,000xg, 10 
min, 4 °C) to remove cell debris. The supernatant was sterile filtered through a 0.45 μm 
cellulose acetate filter into a 6 mL crimp vial, crimp sealed, and the head space of the 
crimp vial was degassed by bubbling argon through for at least 10 min. The concentration 
of cytochrome c protein lysate was determined using the ferrous assay described in 
section (E). Using this protocol, the protein concentrations we typically observed for 
OD600 = 15 lysates are in the 8-15 μM range for wild-type Rma cyt c and 2-10 μM for 
other Rma cyt c variants.  
 
(I) Small-scale biocatalytic reaction.   In an anaerobic chamber, protein lysate (340 
μL) in a 2 mL crimp vial was added 40 μL Na2S2O4 (100 mM in dH2O), 10 μL PhMe2SiH 
(400 or 800 mM in MeCN) and 10 μL Me-EDA (400 mM in MeCN). The vial was crimp 
sealed, removed from the anaerobic chamber, and shaken at 400 rpm at room temperature 
for the stated reaction time. At the end of the reaction, the crimp vial was opened and the 
reaction was quenched with cyclohexane (1 mL). Internal standard was added (20 μL of 
20 mM 2-phenylethanol in cyclohexane) and the reaction mixture was transferred to a 
microcentrifuge tube, vortexed (10 seconds, 3 times), then centrifuged (14,000xg, 5 min) 
to completely separate the organic and aqueous layers (the vortex-centrifugation step was 
repeated if complete phase separation was not achieved). The organic layer (750 μL) was 
removed for GC and SFC analysis. All biocatalytic reactions were performed in triplicate 
unless otherwise stated. The total turnover numbers (TTNs) reported are calculated with 
respect to the protein catalyst and represent the total number of turnovers that is possible 
to obtain from the catalyst under the stated reaction conditions. 
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III. Supporting Tables and Figures 
 
Table S1. Summary of known catalytic systems for enantioselective carbene insertion 
into silicon−hydrogen bonds 
 
Chiral catalytic 
system Ref Reaction condition 
Substrate 
scope TTN % ee 
Copper      
A  (15) CH2Cl2, rt, 18 h 4 17 to 25 17 to 98 
B  (36) C6H6, 0 °C, 13.5 h 1 8 to 10 29 to 78 
C  (14) CH2Cl2, −60 to 0 °C, 2-12 h 24 3 to 19 12 to 99 
B  (37) CH2Cl2, −40 to 0 °C, 48-72 h 8 5 to 9 49 to 88 
B  (38) CH2Cl2, −40 to −10 °C 9 5 to 8 40 to 84 
Iridium      
D  (13) CH2Cl2, −78 or −30 °C, 24 h 15 24 to 50 94 to 99 
E  (39) CH2Cl2, −78 °C, 24 h 7 75 to 94 72 to 91 
Rhodium      
F  (12) CH2Cl2, rt to 40 °C, 6-12 h 34 9 to 30 77 to 99 
G  (40) CH2Cl2, −78 °C or rt, 3-12 h 5 8 to 45 20 to 63 
H  (36) C5H12, −78 to −75 °C, 24 h 1 24 to 70 48 to 97 
I  (11) CF3CH2OH, −35 °C 10 51 to 97 20 to 99 
H  (41) CH2Cl2, −78 °C then rt, 23 h 6 22 to 54 77 to 94 
various Rh(II)-
carboxylate 
(42) 
(43) 
CH2Cl2, rt or −78 °C, 0.5 to 
24 h to overnight 6 <1 to 23 6 to 76 
J (44) CH2Cl2, −78 °C to rt, 23 h 2 35 to 40 38 to 58 
H  (45) CH2Cl2, −78 °C, 1 to 1.5 h 4 34 to 43 35 to 72 
H  (46) C5H12, −78 °C, 24 h 5 13 to 19 75 to 95 
various Rh(II)-
carboxylate (47) CH2Cl2, rt or reflux 1 8 to 17 6 to 47 
 
Catalytic systems that could yield enantiopure products are highlighted in blue. rt = room 
temperature. In cases where the reaction times were not documented in the original 
literature, this information is not shown in the table above. 
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Table S2. Summary of known catalytic systems that accept α-alkyl diazo compounds as 
substrates for enantioselective carbene insertion into silicon−hydrogen bonds  
 
α-Alkyl diazo compounds are challenging substrates for intermolecular carbene-transfer 
chemistry due to their propensity to undergo competing intramolecular β-hydride 
migration (48, 13). As a result, only a subset of catalytic systems shown in Table S1 have 
been reported to accommodate these substrates, as summarized in the table below: 
 
Chiral catalytic 
system Ref Reaction condition 
Substrate 
scope TTN % ee 
Copper      
A  (15) CH2Cl2, rt, 18 h 4 17 to 25 17 to 98 
C  (14) CH2Cl2, −40 °C, 2-12 h 2 3 to 12 12 to 35 
Iridium      
D  (13) CH2Cl2, −78 °C, 24 h 8 24 to 44 94 to 99 
Rhodium      
F  (12) CH2Cl2, rt to 40 °C, 6-12 h 2 11 to 15 70 to 77 
I  (11) CF3CH2OH, −35 °C 1 n.d.§ 64 
H  (41) CH2Cl2, −78 °C then rt, 23 h 5 22 to 54 77 to 94 
  
See Table S1 for chemical structures of chiral catalysts. rt = room temperature. § The 
amount of product formed was not reported in the original literature. 
 
 
Table S3. Summary of known catalytic systems for reaction between 
phenyldimethylsilane and Me-EDA via enantioselective carbene insertion into 
silicon−hydrogen bond 
 
 
 
Chiral catalytic 
system Ref Reaction condition TTN % ee 
Copper     
C  (14) CH2Cl2, −40 °C, 2-12 h 12 35 
Iridium     
D  (13) CH2Cl2, −78 °C, 24 h 43 97 
Rhodium     
F  (12) CH2Cl2, rt to 40 °C, 6-12 h 15 77      
 
See Table S1 for chemical structures of chiral catalysts. rt = room temperature. 
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Table S4. Preliminary experiments with heme and purified heme proteins 
 
 
 
Catalyst TTN % ee 
Controls   
None 0 - 
Hemin 4 ± 1 0 
Hemin + BSA 1 ± 1 0 
P450s   
BM3 P450 T268A (22) 44 ± 15 0 
BM3 P450 T268A C400H (49) 45 ± 3 <5 
BM3 P450 CIS I263F C400S T438S (50) 24 ± 9 <5 
BM3 P450 F87A T268A C400S (51) 40 ± 15 <5 
BM3 P450 Hstar H92N H100N (52) 46 ± 7 0 
Myoglobins   
Sperm whale Mb 12 ± 1 0 
Sperm whale Mb H64V V68A (53) 17 ± 1 0 
Cytochromes c   
Horse heart cyt c 31 ± 10 <5 
Bovine heart cyt c 54 ± 2 6 
S. cerevisiae cyt c 11 ± 1 <5 
R. marinus cyt c 34 ± 10 97 
H. thermophilus cyt c 8 ± 2 16 
R. globiformis cyt c 4 ± 1 <5 
Others   
Horse radish peroxidase 0 - 
C. glutamicum catalase 0 - 
 
Heme proteins that are available commercially or in our laboratory inventory were 
screened to identify the most enantioselective protein variant as starting point for directed 
evolution. Experiments with heme proteins were performed using 10 μM purified heme 
protein, 10 mM silane, 10 mM diazo ester, 10 mM Na2S2O4, 5 vol% MeCN, M9-N buffer 
at room temperature under anaerobic conditions for 1.5 h. Experiments with hemin were 
performed using 100 μM hemin. Experiments with hemin and BSA were performed 
using 100 μM hemin in the presence of BSA (0.75 mg/mL). Reactions were performed in 
triplicate. TTNs reported are the average of three experiments. Within instrument 
detection limit, variability in % ee was not observed. Unreacted starting materials were 
observed at the end of all reactions and no attempt was made to optimize these reactions. 
 
 
 
Si
HPh
+ OEt
O
N2
Catalyst
M9-N buffer (pH 7.4), Na2S2O4
room temperature, 1.5 hours
OEt
O
H
Si
Ph
 
 
10 
 
Table S5. Carbon−silicon bond formation catalyzed by Rma cyt c variants  
 
 
Rma cyt c TTN 
WT 44 ± 27 
M100D 549 ± 24 
V75T 150 ± 48 
M103E 70 ± 21  
V75T M100D 892 ± 20 
V75T M100E 154 ± 37 
M100D M103E 520 ± 88 
V75T M100D M103E 1518 ± 51 
 
Experiments were performed using lysates of E. coli expressing Rma cyt c variant (OD600 
= 15; heat-treated at 75 °C for 10 min), 10 mM silane, 10 mM diazo ester, 10 mM 
Na2S2O4, 5 vol% MeCN, M9-N buffer at room temperature under anaerobic conditions 
for 1.5 h. Reactions were performed in triplicate. TTNs reported are the average of three 
experiments. 
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Table S6. Comparison of carbon−silicon bond forming rates of four generations of Rma 
cyt c  
 
 
 
To determine the initial reaction rate, experiments were performed using purified 
Rma cyt c variant (0.8 μM), 10 mM silane, 10 mM diazo ester, 10 mM Na2S2O4, 5 vol% 
MeCN, M9-N buffer at room temperature under anaerobic conditions for various time 
intervals. See below for experimental procedure. The data used for determining the initial 
rate of each Rma cyt c variant is showed in the following graph: 
 
 
Rma cyt c variant initial rate  / μM min-1 
turnover frequency (TOF) 
/ min-1 
TOF relative 
to WT 
WT 5.1 ± 0.3 6.4 ± 0.3 1 
M100D 14.0 ± 0.4 17.5 ± 0.5 2.8 ± 0.2 
V75T M100D 23.6 ± 0.8 29.5 ± 1.0 4.6 ± 0.3 
V75T M100D M103E 36.4 ± 0.5 45.5 ± 0.7 7.1 ± 0.4 
 
Errors quoted in the table above are calculated from the standard deviations of the fitting 
of data in the product vs time plot. 
 
 
General procedure for carrying out timed experiments 
In an anaerobic chamber, 1 mL Na2S2O4 (100 mM in dH2O) was added to 4 mL 
purified Rma cyt c protein (2.0 μM in M9-buffer) to give Solution 1. To four 2 mL 
microcentrifuge tubes were each added 180 μL M9-N buffer, 10 μL PhMe2SiH (400 mM 
in MeCN) and 10 μL Me-EDA (400 mM in MeCN), and the mixtures were mixed 
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thoroughly on a shaker (480 rpm for 2 min). To these mixtures were added 200 μL 
Solution 1, and the microcentrifuge tubes were closed and quickly shaken by hand for 3 
seconds to ensure thorough mixing, before the tubes were returned to the shaker. The 
reactions were stopped at specific time points (2 min, 4 min, 6 min, and 8 min) by quick 
addition (within 10 seconds) of 40 μL pyridine solution (400 mM in dH2O), 20 μL 
internal standard (20 mM acetophenone in toluene) and 1 mL cyclohexane. (Note: 
pyridine was added as a quencher to significantly slow down the reaction.) After the 
mixtures were vortexed for 20 seconds, 200 μL organic layer was immediately removed 
for GC analysis. 
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Table S7. Rh(II) or Cu(II)-catalyzed reactions between Me-EDA and 4-
(dimethylsilyl)phenol (1k) or  4-(dimethylsilyl)aniline (23) 
 Rh2(OAc)4 and Cu(OTf)2, which are known to catalyze carbene insertion into 
Si−H bonds under ligand-free conditions (54), were tested for their chemoselectivities 
towards Si−H, O−H and N−H insertions: 
 
 
 21 (Si−H insertion) 21-iso (O−H insertion) 21-di (double insertion) 
Rh2(OAc)4 × ✓ ✓ 
Cu(OTf)2 × × × 
 22 (Si−H insertion) 22-iso (N−H insertion) 22-di (double insertion) 
Rh2(OAc)4 × ✓ × 
Cu(OTf)2 × × × 
 
Note: × = not detected; ✓ = detected. Cu(OTf)2 gave complex mixtures of products in 
both reactions. 
 
 
Experimental procedure 
To a 5 mL vial was added silane (0.1 mmol, 1.0 equiv.), metal catalyst (Rh2(OAc)4 
(0.44 mg, 1 mol%) or Cu(OTf)2 (3.62 mg, 10 mol%)) and DCM (0.5 mL). The mixture 
was cooled to −78 °C before a solution of Me-EDA (25 μL, 2.0 equiv.) in DCM (0.3 mL) 
was added dropwise. After slowly warming up to room temperature in 4 hours, the 
reaction mixture was filtrated through a short pad of silica, diluted with DCM, and 
analyzed by GC-MS.  
 
Products isolated from Rh2(OAc)4-catalyzed reactions with 1k and 23 are shown on 
the next page. Both reactions generated multiple products, rendering product purification 
and quantitative analysis of these reactions difficult. Multiple rounds of purification by 
silica column chromatography were required to obtain samples suitable for 
characterization; yields were therefore not determined for these reactions. Notably, Si−H 
insertion products 21 and 22 were not observed in these reactions. 
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(Table S7 continued) 
 
Rh2(OAc)4-catalyzed reaction with 1k gave rac-21–di and rac-21–iso: 
 
rac-21–di  
 1H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 8.6 Hz, 2H), 
6.87 (d, J = 8.7 Hz, 2H), 4.75 (q, J = 6.8 Hz, 1H), 4.22 (q, J = 
7.1 Hz, 2H), 4.01 (q, J = 7.1 Hz, 2H), 2.21 (q, J = 7.1 Hz, 1H), 
1.62 (d, J = 6.8 Hz, 3H), 1.25 (t, J = 7.1 Hz, 3H), 1.17-1.10 
(m, 6H), 0.33 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 176.19, 
172.25, 158.86, 135.54, 128.29, 128.28, 114.65, 72.42, 61.46, 
59.93, 30.30, 18.68, 14.47, 14.28, 11.43, –3.77, –4.60. HRMS 
(FAB) m/z: 352.1714 (M +); calc. for C18H28SiO5: 352.1706. 
 
rac-21–iso (this compound was inseparable from impurities) 
 
1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.7 Hz, 2H), 6.87 (d, J 
= 8.7 Hz, 2H), 4.76 (q, J = 6.8 Hz, 1H), 4.39 (hept, J = 3.7 Hz, 
1H), 4.22 (q, J = 6.9 Hz, 2H), 1.62 (d, J = 6.8 Hz, 3H), 1.26 (t, J = 
7.1 Hz, 3H), 0.31 (d, J = 3.8 Hz, 6H). 
 
 
 
Rh2(OAc)4-catalyzed reaction with 23 gave rac-22-iso and the corresponding double 
N−H insertion product: 
 
rac-22–iso 
1H NMR (400 MHz, CDCl3) δ 7.24-7.17 (m, 2H), 6.88-6.68 (m, 
3H), 4.68 (dq, J = 5.5, 2.8 Hz, 1H), 4.22-4.11 (m, 3H), 1.50 (br d, 
J = 6.4 Hz, 3H), 1.25 (t, J = 7.1 Hz, 3H), 0.19 (d, J = 2.8 Hz, 6H). 
13C NMR (100 MHz, CDCl3) δ 173.94, 135.20, 129.50, 119.78, 
114.93, 61.47, 53.20, 18.62, 14.31, 0.71. HRMS (FAB) m/z: 
250.1253 ((M+H)–H2+); calc. for C13H20SiNO2: 250.1263. 
 
Interestingly, the following compound was also isolated as a mixture of diastereomers. 
The counter anion of the ammonium salt was not determined. 
 
1H NMR (400 MHz, CDCl3) δ 7.22 (overlapping doublets, J = 8.8, 
7.3 Hz, 2H), 6.84 (t, J = 7.3 Hz, 1H), 6.78 (br d, J = 7.9 Hz, 2H), 
4.99-4.55 (m, 1H), 4.44 (q, J = 7.1 Hz, 2H), 4.23 (app qd, J = 7.2, 
2.0 Hz, 4H), 1.55 (d, J = 7.2 Hz, 6H), 1.29 (t, J = 7.1 Hz, 6H), 
0.30-0.19 (m, 6H). 13C NMR (100 MHz, CDCl3) δ 174.40, 146.38, 
128.89, 119.30, 117.17, 61.24, 56.24, 15.95, 14.34, 0.71. HRMS 
(FAB) m/z: 352.1958 (M+); calc. for C18H30SiNO4: 352.1944. 
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Fig. S1 Representative SDS-PAGE gel of purified wild-type Rma cyt c and its V75T 
M100D M103E variant (TDE) in comparison to a standard protein ladder. The 
second and third lanes from the left are the same samples loaded at lower protein 
concentration. 
 
 
Fig. S2 Circular dichroism (CD) spectra of purified Rma cyt c V75T M100D M103E 
(Rma TDE). 
 
Rma cyt c V75T M100D M103E was purified without performing the heat treatment step.  
Two identical samples were prepared in M9-N buffer, and one was heat treated at 75 °C 
for 10 minutes. After cooling to room temperature, the samples were analyzed by CD. 
The CD spectra of heat-treated and untreated Rma cyt c V75T M100D M103E are 
identical, suggesting that heat treatment at 75 °C for 10 minutes does not cause 
irreversible denaturation of the protein. The ΔεMRW values shown here are similar to 
previously published values for wild-type Rma cyt c (26), which suggests mutations 
V75T, M100D, and M103E are not highly disruptive to the protein secondary structure. 
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Fig. S3 Working hypothesis of binding mode for the iron carbenoid in wild-type 
Rma cyt c and speculated reaction trajectory for carbon−silicon bond formation. 
 
 
 
 
 
(A) Putative active site structure of wild-type Rma cyt c showing residues V75, M100, 
and M103 (PDB ID: 3CP5). (B) Proposed binding mode for the iron-carbenoid, where 
the carbenoid forms in a way that takes the place of the axial methionine. The silane is 
proposed to approach from the more solvent-exposed side in the wild-type protein, which 
explains the observed stereochemistry of the organosilicon product. The V75T, M100D, 
and M103E mutations may promote reactivity by improving solvent and substrate access 
to the iron center. It should be noted that the working hypothesis proposed here is highly 
speculative as structural data about the ability of bacterial cytochrome c proteins to bind 
organic molecules is practically non-existent.  
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Fig. S4 Example of reaction time course of purified Rma cyt c M100D V75T M103E-
catalyzed reaction between phenyldimethylsilane and Me-EDA. 
 
 
 
Experiments were performed using 3 μM purified Rma cyt c V75T M100D M103E, 10 
mM silane, 10 mM diazo ester, 10 mM Na2S2O4, 5 vol% MeCN, M9-N buffer at room 
temperature under anaerobic conditions. Reactions were performed in duplicate. TTNs 
shown are the average of two experiments. 
It is possible that catalysis slows down and ultimately stops due to catalyst inactivation 
by carbene transfer to the protein, an inactivation mechanism we recently analyzed in 
detail in another carbene-transfer enzyme (52). The activity and lifetime of Rma cyt c 
would likely improve by identifying the protein residues affected by mechanism-based 
inhibitors and further mutagenesis studies. Furthermore, inactivation of whole-cell 
catalyst was previously found to be slower than purified enzyme (52); this might also be 
applicable to Rma cyt c in whole bacterial cell.  
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Fig. S5 Additional substrates tested for Rma cyt c V75T M100D M103E-catalyzed 
carbon−silicon bond formation. 
 
 
 
 
Rma cyt c V75T M100D M103E-catalyzed reactions of silanes Si-A-H were tested with 
Me-EDA and that of diazo compounds diazo-A-C were tested with phenyldimethylsilane 
under standard in vitro biocatalytic reaction conditions. Product formation was analyzed 
by GC-MS only, and comparison with chemically synthesized reference standards was 
not made. These preliminary results should be interpreted with caution and should not be 
used alone for drawing conclusions.  
Si-A-D and diazo-A: formation of organosilicon product was detected by GC-MS. 
Si-E-H and diazo-B-C: formation of organosilicon product was not detected by GC-MS. 
Because biocatalysts that are fully genetically encoded can be readily optimized by 
directed evolution, the Rma cyt c V75T M100D M103E variant presented in this report is 
not the end point, but rather a parent to hundreds and thousands of future enzyme 
variants, some of which will most certainly surpass the scope and activity of the parent 
enzyme. For substrate scope expansion or other future applications, we suggest using the 
substrate of interest for directed evolution, and carrying out reaction screening under 
condition that suits individual substrate.  
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Fig. S6 Hammett analysis of Rma cyt c V75T M100D M103E-catalyzed 
carbon−silicon bond formation 
 
R kR / kH log(kR / kH) σ 
H 1 0 0 
MeO 1.3 0.13 −0.27 
NH2 3.2 0.50 −0.66 
Cl 0.78 −0.11 0.23 
CO2Me 0.47 −0.32 0.45 
 
 
The Hammett plot suggests a small build-up of positive charge on the silane in the 
reaction transition state. This observation is similar to that reported for carbene insertion 
into Si−H bond catalyzed by copper (ρ = −0.54) (37) and rhodium (ρ = −0.31) (55). 
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IV. Substrate Synthesis and Characterization  
Commercially available substrates were used as received: phenyldimethylsilane 
(Sigma-Aldrich), benzyldimethylsilane (Sigma-Aldrich), ethyl 2-diazopropanoate (Arch 
Bioscience). The following diazo compounds are known and prepared according to 
literature procedures: isopropyl 2-diazopropanoate (56), ethyl 2-diazobutanoate (57). 
 
 
Dimethyl(p-tolyl)silane (1b) 
 
In a 100 mL round-bottom flask, chlorodimethylsilane (1.11 mL, 10.0 
mmol) in THF (6 mL) was cooled to 0 °C. A solution of 4-
methylphenylmagnesium bromide (24 mL, 0.5 M in THF) was added 
dropwise slowly over 15 min. Then reaction was allowed to warm to 
room temperature and stirred for 8 hours. The reaction mixture was quenched with 
NH4Cl (5 mL, sat. aq.) and the product was extracted with Et2O (15 mL × 3). The organic 
layer was washed with water (20 mL), brine (20 mL), dried over MgSO4, and then 
concentrated under reduced pressure (200 torr). The crude product was purified by silica 
column chromatography with pentane to afford 1b (1.27 g, 8.44 mmol, 84%). This 
compound is known (58). 1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 7.8 Hz, 2H), 7.23 
(d, J = 7.4 Hz, 2H), 4.46 (hept, J = 3.7 Hz, 1H), 2.39 (s, 3H), 0.37 (d, J = 3.7 Hz, 6H). 
 
 
(4-Methoxyphenyl)dimethylsilane (1c) 
 
In a 100 mL round-bottom flask, chlorodimethylsilane (1.11 mL, 
10.0 mmol) in THF (6 mL) was cooled to 0 °C. A solution of 4-
methoxyphenylmagnesium bromide (24 mL, 0.5 M in THF) was 
added dropwise slowly over 15 min. Then reaction was allowed to 
warm to room temperature and stirred for 8 hours. The reaction mixture was quenched 
with NH4Cl (5 mL, sat. aq.) and the product was extracted with Et2O (15 mL × 3). The 
organic layer was washed with water (20 mL), brine (20 mL), dried over MgSO4, and 
then concentrated under reduced pressure (200 torr). The crude product was purified by 
silica column chromatography with pentane / Et2O (10: 1) to afford 1c (1.60 g, 9.62 
mmol, 96%). This compound is known (58). 1H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 
8.7 Hz, 2H), 6.96 (d, J = 8.6 Hz, 2H), 4.75-4.19 (m, 1H), 3.85 (s, 3H), 0.37 (d, J = 3.8 
Hz, 6H). 
 
 
(4-Chlorophenyl)dimethylsilane (1d) 
 
In a 100 mL round-bottom flask, chlorodimethylsilane (1.11 mL, 10.0 
mmol) in THF (6 mL) was cooled to 0 °C. A solution of 4-
chlorophenylmagnesium bromide (24 mL, 0.5 M in THF) was added 
dropwise slowly over 15 min. Then reaction was allowed to warm to 
room temperature and stirred for 8 hours. The reaction mixture was quenched with 
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NH4Cl (5 mL, sat. aq.) and the product was extracted with Et2O (15 mL × 3). The organic 
layer was washed with water (20 mL), brine (20 mL), dried over MgSO4, and then 
concentrated under reduced pressure (200 torr). The crude product was purified by silica 
column chromatography with pentane to afford 1d (1.27 g, 7.45 mmol, 75%). This 
compound is known (58). 1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 8.3 Hz, 2H), 7.34 
(d, J = 8.2 Hz, 2H), 4.41 (hept, J = 3.8 Hz, 1H), 0.34 (d, J = 3.7 Hz, 6H). 
 
 
(4-(Trifluoromethyl)phenyl)dimethylsilane (1e) 
 
In a 100 mL round-bottom flask, 1-bromo-4-(trifluoromethyl)benzene 
(1.4 mL, 10.0 mmol) in THF (15 mL) was cooled to −78 °C. n-BuLi 
(7.5 mL, 1.6 M in hexane) was added dropwise slowly over 15 min. 
The resulting mixture was stirred at −78 °C for 2 hours before the 
dropwise addition of chlorodimethylsilane (1.0 mL, 9.0 mmol). The reaction was allowed 
to warm to room temperature and stirred for 8 hours. The reaction mixture was quenched 
with NH4Cl (5 mL, sat. aq.) and the product was extracted with Et2O (15 mL × 3). The 
organic layer was washed with water (20 mL), brine (20 mL), dried over MgSO4, and 
then concentrated under reduced pressure (200 torr). The crude product was purified by 
silica column chromatography with pentane to afford 1e (0.81 g, 3.97 mmol, 40%). This 
compound is known (58). 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 7.7 Hz, 2H), 7.60 
(d, J = 7.9 Hz, 2H), 4.46 (hept, J = 3.8 Hz, 1H), 0.38 (d, J = 3.8 Hz, 6H).  
 
 
(4-(Chloromethyl)phenyl)dimethylsilane (1f) 
 
In a 250 mL round-bottom flask, (4-bromophenyl)methanol (5.61 g, 
30.0 mmol) in THF (100 mL) was cooled to −78 °C. n-BuLi (30.0 
mL, 2.5 M in hexane) was added dropwise slowly over 30 min. The 
resulting mixture was stirred at −78 °C for 2 hours before the 
dropwise addition of chlorodimethylsilane (4.5 mL, 40.0 mmol). The reaction was 
allowed to warm to room temperature and stirred for 8 hours. The reaction mixture was 
quenched with NH4Cl (50 mL, sat. aq.) and the product was extracted with DCM (50 mL 
× 3). The organic layer was washed with water (20 mL), brine (20 mL), dried over 
MgSO4, and then concentrated under reduced pressure (100 torr). The crude product was 
purified by silica column chromatography with EtOAc / hexane (1:3) to afford (4-
(dimethylsilyl)phenyl)methanol (2.96 g, 17.8 mmol, 59%). This compound is known 
(59). 1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.1 Hz, 2H), 
4.70 (s, 2H), 4.43 (hept, J = 3.7 Hz, 1H), 0.35 (d, J = 3.8 Hz, 6H). 
To a solution of (4-(dimethylsilyl)phenyl)methanol (498.9 mg, 3.0 mmol) in DCM 
(4 mL) were added triethylamine (0.5 mL, 3.6 mmol) and 4-methylbenzenesulfonyl 
chloride (629.1 mg, 3.3 mmol). The reaction mixture was stirred at room temperature for 
8 hours. The reaction was then diluted with DCM (10 mL) and washed with water (20 
mL), brine (20 mL), dried over MgSO4, and the organic layer was concentrated under 
reduced pressure (100 torr). The crude product was purified by silica column 
chromatography with pentane to afford 1f (0.22 g, 1.19 mmol, 40%). 1H NMR (400 
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MHz, CDCl3) δ 7.55 (d, J = 8.0 Hz, 2H), 7.39 (d, J = 7.9 Hz, 2H), 4.59 (s, 2H), 4.43 
(hept, J = 3.8 Hz, 1H), 0.35 (d, J = 3.8 Hz, 6H). HRMS (FAB) m/z: 183.0399 ((M+H)–
H2+); calc. for C9H12SiCl: 183.0397. 
 
 
Methyl 4-(dimethylsilyl)benzoate (1g) 
 
In a 100 mL round-bottom flask, methyl 4-iodobenzoate (2.62 g, 
10.0 mmol) in THF (15 mL) was cooled to –78 °C. i-PrMgCl (6 
mL, 2.0 M in Et2O) was added dropwise slowly over 5 min. The 
resulting mixture was allowed to warm to –40 °C in 2 hours and 
maintained at –40 °C for another 2 hours before the dropwise 
addition of chlorodimethylsilane (1.2 mL, 11.0 mmol). The reaction was allowed to warm 
to room temperature and stirred for 8 hours. The reaction mixture was quenched with 
NH4Cl (5 mL, sat. aq.) and the product was extracted with DCM (15 mL × 3). The 
organic layer was washed with water (20 mL), brine (20 mL), dried over MgSO4, and 
then concentrated under reduced pressure (100 torr). The mixture was dissolved in Et2O 
(5 mL) and treated with hexane (25 mL). This crashed out most of the starting material, 
which was removed by filtration. The filtrate was collected, concentrated under reduced 
pressure, and purified by silica column chromatography with EtOAc / hexane (1:20) to 
afford 1g (0.88 g, 4.53 mmol, 45%). 1H NMR (400 MHz, CDCl3) δ 8.00 (d, J = 8.1 Hz, 
2H), 7.62 (d, J = 8.2 Hz, 2H), 4.45 (hept, J = 3.8 Hz, 1H), 3.92 (s, 3H), 0.37 (d, J = 3.8 
Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 167.35, 143.92, 134.13, 130.78, 128.72, 52.27, –
3.84. HRMS (FAB) m/z: 195.0843 (M+H+); calc. for C10H15SiO2: 195.0841. 
 
 
4-(dimethylsilyl)-N,N-dimethylbenzamide (1h) 
 
To a solution of dimethylamine hydrochloride (2.45 g, 30.0 
mmol) in DCM (50 mL) was added triethylamine (4.2 mL, 30.0 
mmol). The mixture was stirred for 30 min before the addition of 
4-iodobenzoic acid (6.20 g, 25.0 mmol) and 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide (EDC, 4.66 g, 30.0 
mmol). The reaction was stirred for 8 hours at room temperature. Then the reaction 
mixture was washed with water (50 mL), HCl (aq., 1 M, 50 mL), NaHCO3 (sat. aq., 50 
mL) and brine (50 mL), dried over MgSO4, and then concentrated under reduced pressure 
(50 torr). The crude product was dissolved in Et2O (5 mL) and treated with hexane (50 
mL). The target product 4-iodo-N,N-dimethylbenzamide (6.88 g, 25.0 mmol, 
quantitative) crashed out and was collected by filtration.  
In a 100 mL round-bottom flask, 4-iodo-N,N-dimethylbenzamide (1.65 g, 6.0 mmol) 
in THF (15 mL) was cooled to –78 °C. i-PrMgCl (6 mL, 2.0 M in Et2O) was added 
dropwise slowly over 5 min. The resulting mixture was allowed to warm to –40 °C 
within 2 hours and maintained at –40 °C for another 2 hours before the dropwise addition 
of chlorodimethylsilane (1.3 mL, 12.0 mmol). The reaction was allowed to warm to room 
temperature and stirred for 8 hours. The reaction mixture was quenched with NH4Cl (5 
mL, sat. aq.) and the product was extracted with DCM (15 mL × 3). The organic layer 
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was washed with water (20 mL), brine (20 mL), dried over MgSO4, and then 
concentrated under reduced pressure (50 torr). The mixture was dissolved in Et2O (5 mL) 
and treated with hexane (25 mL). Most of the starting material crashed out and was 
removed by filtration. The filtrate was collected, concentrated under reduced pressure, 
and then purified by silica column chromatography with EtOAc / hexane (1:2) to afford 
1h (0.12 g, 0.579 mmol, 10%). 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.3 Hz, 2H), 
7.39 (d, J = 8.3 Hz, 2H), 4.43 (hept, J = 3.8 Hz, 1H), 3.05 (s, 6H), 0.35 (d, J = 3.7 Hz, 
6H). 13C NMR (100 MHz, CDCl3) δ 171.74, 139.53, 137.04, 134.11, 126.42, –3.74. 
HRMS (FAB) m/z: 208.1153 (M+H+); calc. for C11H18ONSi: 208.1158. 
 
 
(3,4-Dihydro-2H-pyran-6-yl)dimethylsilane (1i) 
 
 
In a 100 mL round-bottom flask, 3,4-dihydro-2H-pyran (2.00 g, 24.0 
mmol) in THF (1.0 mL) and pentane (40 mL) was cooled to –78 °C. t-
BuLi (15.5 mL, 1.7 M in pentane) was added dropwise slowly over 20 
min. The resulting mixture was allowed to warm to 0 °C within 2 hours and maintained at 
0 °C for another 2 hours before the dropwise addition of chlorodimethylsilane (2.6 mL, 
24.0 mmol). The reaction was allowed to warm to room temperature and stirred for 8 
hours. The reaction mixture was quenched with NH4Cl (5 mL, sat. aq.) and the product 
was extracted with Et2O (15 mL × 3). The organic layer was washed with water (20 mL), 
brine (20 mL), dried over MgSO4, and then concentrated under reduced pressure (200 
torr). The crude product was purified by silica column chromatography with Et2O / 
pentane (1: 30) to afford 1i (2.80 g, 19.7 mmol, 82%). This compound is known (60). 1H 
NMR (400 MHz, CDCl3) δ 5.09 (t, J = 3.8 Hz, 1H), 4.05-3.91 (m, 3H), 2.04 (td, J = 6.4, 
3.8 Hz, 2H), 1.92-1.83 (m, 2H), 0.19 (d, J = 3.8 Hz, 6H).  
 
 
4-(Dimethylsilyl)phenol (1k) 
 
To a solution of 4-bromophenol (1.73 g, 10.0 mmol) in THF (15 mL) 
was added NaH (60% in mineral oil, 0.48 g, 12.0 mmol). After the 
mixture was stirred for 30 min, it was cooled down to –78 °C. t-BuLi 
(6 mL, 1.7 M in pentane) was added dropwise slowly over 15 min. 
The resulting mixture was stirred at –78 °C for 2 hours before the dropwise addition of 
chlorodimethylsilane (2.3 mL, 21.0 mmol). The reaction was allowed to warm to room 
temperature and stirred for 8 hours. The reaction mixture was quenched with NH4Cl (5 
mL, sat. aq.) and the product was extracted with DCM (15 mL × 3). The organic layer 
was washed with water (20 mL), brine (20 mL), dried over MgSO4, and then concentrated 
under reduced pressure (50 torr). The crude product was purified by silica column 
chromatography with EtOAc / hexane (1:7) to afford 1k (0.60 g, 3.94 mmol, 39%). This 
compound is known (61). 1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.5 Hz, 2H), 6.85 
(d, J = 8.5 Hz, 2H), 4.78 (s, 1H), 4.40 (hept, J = 3.7 Hz, 1H), 0.32 (d, J = 3.8 Hz, 6H). 13C 
NMR (100 MHz, CDCl3) δ 156.61, 135.82, 128.66, 115.16, –3.38. 
 
 
 
24 
 
 
(4-(Benzyloxy)phenyl)dimethylsilane (1ks) 
 
To a solution of 4-bromophenol (5.19 g, 30.0 mmol) in MeCN 
(50 mL) was added K2CO3 (5.53 g, 40.0 mmol). After the 
mixture was stirred at 40 °C for 30 min, BnBr (3.6 mL, 30.0 
mmol) was added over 2 min. The resulting mixture was 
stirred at 40 °C for 3 hours. The reaction mixture was washed 
with water (20 mL), brine (20 mL), dried over MgSO4, and then concentrated under 
reduced pressure (50 torr) to afford the crude product 1-(benzyloxy)-4-bromobenzene 
(7.85 g, 30.0 mmol, quantitative).  
In a 100 mL round-bottom flask, 1-(benzyloxy)-4-bromobenzene (6.57 g, 25.0 
mmol) in THF (15 mL) was cooled to –78 °C. t-BuLi (19.0 mL, 1.7 M in pentane) was 
added dropwise slowly over 15 min. The resulting mixture was stirred at –78 °C for 2 
hours before the dropwise addition of chlorodimethylsilane (3.6 mL, 32.5 mmol). The 
reaction was allowed to warm to room temperature and stirred for 8 hours. The reaction 
mixture was quenched with NH4Cl (5 mL, sat. aq.) and the product was extracted with 
Et2O (15 mL × 3). The organic layer was washed with water (20 mL), brine (20 mL), 
dried over MgSO4, and then concentrated under reduced pressure (50 torr). The crude 
product was purified by silica column chromatography with pentane to afford 1ks (4.02 
g, 16.6 mmol, 66%). 1H NMR (400 MHz, CDCl3) δ 7.51-7.27 (m, 7H), 7.00 (d, J = 8.6 
Hz, 2H), 5.08 (s, 2H), 4.41 (hept, J = 3.7 Hz, 1H), 0.32 (d, J = 3.7 Hz, 6H). HRMS 
(FAB) m/z: 241.1053 ((M+H)–H2 +); calc. for C15H17OSi: 241.1049. 
 
 
4-(Dimethylsilyl)aniline (23) 
 
To a solution of 4-bromoaniline (3.44 g, 20.0 mmol) in DCM (30 
mL) was added triethylamine (5.6 mL, 20.0 mmol) and N,N-
dimethylpyridin-4-amine (DMAP, 244.3 mg, 2.0 mmol). After the 
mixture was stirred for 30 min, 1,2-bis(chlorodimethylsilyl)ethane 
(4.78 g, 20.0 mmol) was added in one portion. The reaction was stirred at 40 °C for 3 
hours. The reaction mixture was filtrated through a pad of dry Celite quickly to remove 
the triethylamine hydrochloride. The resulting solution was concentrated under reduced 
pressure (50 torr) to afford the crude product 1-(4-bromophenyl)-2,2,5,5-tetramethyl-
1,2,5-azadisilolidine. (Note: this compound is moisture sensitive and decomposed on 
silica.)  
The crude 1-(4-bromophenyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine in THF (30 
mL) in a 100 mL round-bottom flask was cooled to –78 °C. t-BuLi (17.6 mL, 1.7 M in 
pentane) was added dropwise slowly over 15 min. The resulting mixture was stirred at –
78 °C for 2 hours before the dropwise addition of chlorodimethylsilane (3.3 mL, 30.0 
mmol). The reaction was allowed to warm to room temperature and stirred for 8 hours. 
The reaction mixture was treated with Et2O (50 mL) to allow the inorganic salts to crash 
out. The suspension was filtrated through a pad of Celite and basic alumina (1:1 mixture). 
The resulting solution was concentrated under reduced pressure (50 torr). The crude 
product was loaded on silica and allowed to sit for 15 min (for removal of the nitrogen 
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protecting group), before purification by silica column chromatography with EtOAc / 
hexane (1:7) to afford 23 (1.21 g, 8.00 mmol, 40%). This compound is known (62). 1H 
NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.4 Hz, 2H), 6.83 (d, J = 8.4 Hz, 2H), 4.84 (s, 
2H), 4.38 (hept, J = 3.9 Hz, 1H), 0.30 (d, J = 3.7 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 
144.82, 135.48, 127.64, 116.07, –3.38. 
 
 
Benzyl (4-(dimethylsilyl)phenyl)carbamate (23s) 
 
To a solution of 4-(dimethylsilyl)aniline (151.2 mg, 1.0 
mmol) in DCM (3 mL) was added pyridine (162 μL, 2.0 
mmol). After the mixture was stirred for 10 min, benzyl 
carbonochloridate (CbzCl, 170 μL, 1.2 mmol) was added 
in one portion. After stirring at room temperature 
overnight, the reaction mixture was washed with water 
(20 mL), brine (20 mL), dried over MgSO4, and then concentrated under reduced pressure 
(50 torr). The crude product was purified by silica column chromatography with EtOAc / 
hexane (1:7) to afford 23s (130.4 mg, 0.457 mmol, 46%). 1H NMR (400 MHz, CDCl3) δ 
7.50 (d, J = 8.4 Hz, 2H), 7.46-7.33 (m, 5H), 6.68 (s, 1H), 5.23 (s, 2H), 4.42 (hept, J = 3.7 
Hz, 1H), 0.34 (d, J = 3.7 Hz, 6H). HRMS (FAB) m/z: 286.1274 (M+H+); calc. for 
C16H20O2NSi: 286.1263. 
 
 
(4-Ethynylphenyl)dimethylsilane (1m) 
 
A solution of ((4-bromophenyl)ethynyl)trimethylsilane (5.06 g, 20.0 
mmol) and K2CO3 (5.53 g, 40.0 mmol) in MeOH (40 mL) was stirred 
at room temperature for 4 hours. MeOH was removed under reduced 
pressure, and the crude product was washed with water (30 mL) and 
extracted with Et2O (40 mL). The organic layer was dried over 
MgSO4, filtrated through a pad of silica, and concentrated under reduced pressure to 
afford the product 1-bromo-4-ethynylbenzene (3.21 g, 17.7 mmol, 89%). 
In a 100 mL round-bottom flask, 1-bromo-4-ethynylbenzene (1.81 g, 10.0 mmol) in 
THF (15 mL) was cooled to –78 °C. n-BuLi (8.0 mL, 2.5 M in hexane) was added 
dropwise very slowly over 30 min. The resulting mixture was stirred at –78 °C for 2 
hours before the dropwise addition of a solution of chlorodimethylsilane (1.1 mL, 10.0 
mmol) in THF (20 mL). The reaction was allowed to warm to room temperature and 
stirred for 8 hours. The reaction mixture was quenched with NH4Cl (5 mL, sat. aq.) and 
the product was extracted with Et2O (15 mL × 3). The organic layer was washed with 
water (20 mL), brine (20 mL), dried over MgSO4, and then concentrated under reduced 
pressure (200 torr). The crude product was purified by distillation under reduced pressure 
(1.4 torr) at 45 °C (1.12 g, 6.99 mmol, 70%). This compound is known (63). 1H NMR 
(400 MHz, CDCl3) δ 7.49 (d, J = 3.9 Hz, 4H), 4.42 (hept, J = 3.8 Hz, 1H), 3.10 (s, 1H), 
0.34 (d, J = 3.8 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 138.83, 134.01, 131.43, 122.91, 
83.81, 77.85, –3.77. 
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Dimethyl(4-vinylphenyl)silane (1n) 
 
In a 100 mL round-bottom flask, 1-bromo-4-vinylbenzene (1.83 g, 
10.0 mmol) in THF (15 mL) was cooled to –78 °C. n-BuLi (7.5 mL, 
1.6 M in hexane) was added dropwise very slowly over 30 min. The 
resulting mixture was stirred at –78 °C for 2 hours before the 
dropwise addition of a solution of chlorodimethylsilane (1.1 mL, 10.0 mmol) in THF (20 
mL). The reaction was allowed to warm to room temperature and stirred for 8 hours. The 
reaction mixture was quenched with NH4Cl (5 mL, sat. aq.) and the product was extracted 
with Et2O (15 mL × 3). The organic layer was washed with water (20 mL), brine (20 
mL), dried over MgSO4, and then concentrated under reduced pressure (200 torr). The 
crude product was purified by silica column chromatography with pentane to afford 1n 
(1.29 g, 7.95 mmol, 80%). This compound is known (64). 1H NMR (400 MHz, CDCl3) δ 
7.51 (d, J = 8.1 Hz, 2H), 7.41 (d, J = 7.9 Hz, 2H), 6.72 (dd, J = 17.6, 10.9 Hz, 1H), 5.79 
(dd, J = 17.6, 0.9 Hz, 1H), 5.27 (dd, J = 10.9, 0.9 Hz, 1H), 4.43 (hept, J = 3.7 Hz, 1H), 
0.35 (d, J = 3.8 Hz, 6H). 
 
 
Cyclohexa-2,5-dien-1-yldimethylsilane (1o) 
 
In a 100 mL round-bottom flask, cyclohexa-1,4-diene (2.3 mL, 24.0 mmol) 
in THF (20 mL) was cooled to –78 °C. t-BuLi (15.5 mL, 1.7 M in pentane) 
and N,N,N’,N’-tetramethylethane-1,2-diamine (TMEDA, 3.6 mL, 24 mmol) 
were added simultaneously as separate solutions, dropwise over 20 min. 
The resulting mixture was allowed to warm to –45 °C in 30 min and maintained at –45 
°C for another 1 hour before the dropwise addition of chlorodimethylsilane (2.6 mL, 24.0 
mmol). The reaction was allowed to warm to room temperature and stirred for 1.5 hours. 
The reaction mixture was quenched with NH4Cl (5 mL, sat. aq.) and the product was 
extracted with Et2O (15 mL × 3). The organic layer was washed with water (20 mL), 
brine (20 mL), dried over MgSO4, and then concentrated under reduced pressure (300 
torr). The crude product was purified by silica column chromatography with pentane to 
afford 1o (1.24 g, 8.97 mmol, 38%). (Note: this compound is oxygen sensitive and very 
volatile; storage under argon at –20°C is recommended.) This compound is known (65). 
1H NMR (400 MHz, CDCl3) δ 5.72-5.64 (m, 2H), 5.61-5.54 (m, 2H), 3.85 (heptd, J = 3.5, 
1.6 Hz, 1H), 2.80-2.60 (m, 2H), 2.42-2.30 (m, 1H), 0.10 (d, J = 3.7 Hz, 6H). 13C NMR 
(100 MHz, CDCl3) δ 125.91, 122.09, 29.38, 26.50, –6.31. 
 
 
Dimethyl(naphthalen-2-yl)silane (1p) 
 
In a 100 mL round-bottom flask, 2-bromonaphthalene (2.07 g, 10.0 
mmol) in THF (15 mL) was cooled to –78 °C. n-BuLi (7.5 mL, 1.6 M in 
hexane) was added dropwise very slowly over 30 min. The resulting 
mixture was stirred at –78 °C for 2 hours before the dropwise addition of 
a solution of chlorodimethylsilane (1.1 mL, 10.0 mmol) in THF (20 mL). 
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The reaction was allowed to warm to room temperature and stirred for 8 hours. The 
reaction mixture was quenched with NH4Cl (5 mL, sat. aq.) and the product was extracted 
with Et2O (15 mL × 3). The organic layer was washed with water (20 mL), brine (20 
mL), dried over MgSO4, and then concentrated under reduced pressure (100 torr). The 
crude product was purified by silica column chromatography with pentane to afford 1p 
(1.69 g, 9.07 mmol, 91%). This compound is known (66). 1H NMR (400 MHz, CDCl3) δ 
8.05 (s, 1H), 7.87-7.82 (m, 3H), 7.61 (dd, J = 8.1, 1.0 Hz, 1H), 7.51-7.48 (m, 2H), 4.56 
(hept, J = 3.8 Hz, 1H), 0.43 (d, J = 3.8 Hz, 6H). 
 
 
Benzofuran-2-yldimethylsilane (1q) 
 
In a 100 mL round-bottom flask, benzofuran (1.18 g, 10.0 mmol) in 
THF (15 mL) was cooled to –78 °C. n-BuLi (7.5 mL, 1.6 M in hexane) 
was added dropwise slowly over 20 min. The resulting mixture was 
allowed to warm to –40 °C within 1 hour and maintained at –40 °C for 
another 2 hours before the dropwise addition of chlorodimethylsilane (1.1 mL, 10.0 
mmol). The reaction was allowed to warm to room temperature and stirred for 8 hours. 
The reaction mixture was quenched with NH4Cl (5 mL, sat. aq.) and the product was 
extracted with Et2O (15 mL × 3). The organic layer was washed with water (20 mL), 
brine (20 mL), dried over MgSO4, and then concentrated under reduced pressure (100 
torr). The crude product was purified by silica column chromatography with Et2O / 
pentane (1:30) to afford 1q (1.08 g, 6.13 mmol, 61%). This compound is known (67). 1H 
NMR (400 MHz, CDCl3) δ 7.59 (ddd, J = 7.1, 1.3, 0.7 Hz, 1H,), 7.52 (dd, J = 8.5, 0.5 Hz, 
1H), 7.30 (ddd, J = 8.5, 7.5, 1.0 Hz, 1H), 7.22 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 7.04 (d, J = 
0.7 Hz, 1H), 4.52 (hept, J = 3.8 Hz, 1H), 0.44 (d, J = 3.8 Hz, 6H). 
 
 
Benzothiophen-2-yldimethylsilane (1r) 
 
In a 100 mL round-bottom flask, benzothiophene (1.34 g, 10.0 
mmol) in THF (15 mL) was cooled to –78 °C. n-BuLi (7.5 mL, 1.6 M 
in hexane) was added dropwise slowly over 20 min. The resulting 
mixture was allowed to warm to –40 °C within 1 hour and maintained 
at –40 °C for another 2 hours before the dropwise addition of chlorodimethylsilane (1.1 
mL, 10.0 mmol). The reaction was allowed to warm to room temperature and stirred for 8 
hours. The reaction mixture was quenched with NH4Cl (5 mL, sat. aq.) and the product 
was extracted with Et2O (15 mL × 3). The organic layer was washed with water (20 mL), 
brine (20 mL), dried over MgSO4, and then concentrated under reduced pressure (100 
torr). The crude product was purified by silica column chromatography with pentane to 
afford 1r (1.76 g, 9.14 mmol, 91%). 1H NMR (400 MHz, CDCl3) δ 7.92-7.86 (m, 1H), 
7.86-7.79 (m, 1H), 7.53 (s, 1H), 7.38-7.30 (m, 2H), 4.63 (hept, J = 3.7 Hz, 1H), 0.46 (d, J 
= 3.7 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 143.87, 141.08, 138.57, 132.18, 124.47, 
124.20, 123.63, 122.32, –2.93. HRMS (FAB) m/z: 191.0354 (M–H–); calc. for C10H12SSi: 
191.0351. 
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V. Synthesis and Characterization of Authentic Organosilicon Products  
 
Racemic standard references of organosilicon products were prepared using 
rhodium-catalyzed Si–H insertion reactions, following the general procedure described 
below: 
 
General procedure for rhodium-catalyzed Si–H insertion 
To a 20 mL vial or 25 mL flask was added silane (1.0 mmol, 1.0 equiv.), Rh2(OAc)4 
(4.4 mg, 1 mol%) and DCM (5 mL). The mixture was cooled to –78 °C, after which 
diazo compound (1.0 mmol, 1.0 equiv.) was added dropwise to the solution. The reaction 
was allowed to slowly warm up to room temperature in 8 hours and stirred at room 
temperature for another 4 hours. Evaporation of the organic solvent and purification by 
silica column chromatography using EtOAc and hexane as eluents afforded organosilicon 
products 3-20 in 20-70% yields. 
 
Organosilicon compounds 21 and 22 were prepared by rhodium-catalyzed Si–H 
insertion between Me-EDA and the corresponding O- or N-protected silane (1ks or 23s) 
to give 21a or 22a, followed by deprotection under standard palladium-catalyzed 
hydrogenation condition (10% Pd/C in ethanol under H2 atmosphere at room temperature 
for 16 hours). The hydrogenation reaction afforded 21 and 22 in 96% and 88% yield, 
respectively. 
 
 
Ethyl 2-(dimethyl(phenyl)silyl)propanoate (3) 
 
1H NMR (400 MHz, CDCl3) δ 7.55-7.46 (m, 2H), 7.43-7.32 (m, 3H), 4.02 
(q, J = 7.1 Hz, 2H), 2.25 (q, J = 7.1 Hz, 1H), 1.17-1.11 (m, 6H), 0.37 (d, J = 
0.6 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 176.13, 136.42, 133.99, 129.57, 
127.92, 59.96, 30.14, 14.43, 11.42, –3.92, –4.77. HRMS (FAB) m/z: 
236.1234 (M+); calc. for C13H20O2Si: 236.1233. 
 
 
 
Ethyl 2-(dimethyl(p-tolyl)silyl)propanoate (4) 
 
1H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 7.9 Hz, 2H), 7.18 (d, J = 
7.5 Hz, 2H), 4.03 (q, J = 7.1 Hz, 2H), 2.35 (s, 3H), 2.24 (q, J = 7.1 Hz, 
1H), 1.19-1.11 (m, 6H), 0.35 (d, J = 0.4 Hz, 6H). 13C NMR (100 MHz, 
CDCl3) δ 176.21, 139.51, 134.04, 132.72, 128.77, 59.94, 30.22, 21.63, 
14.47, 11.44, –3.75, –4.75. 29Si NMR (79 MHz, CDCl3) δ 0.19. HRMS 
(FAB) m/z: 250.1391 (M+); calc. for C14H22O2Si: 250.1389. 
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Ethyl 2-(dimethyl(4-methoxyphenyl)silyl)propanoate (5) 
 
1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.6 Hz, 2H), 6.91 (d, J = 
8.6 Hz, 2H), 4.03 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 2.22 (q, J = 7.1 
Hz, 1H), 1.20-1.10 (m, 6H), 0.35 (s, 6H). 13C NMR (100 MHz, 
CDCl3) δ 176.24, 160.84, 135.49, 127.18, 113.70, 59.93, 55.18, 
30.37, 14.49, 11.45, –3.72, –4.58. 29Si NMR (79 MHz, CDCl3) δ –
0.10. HRMS (FAB) m/z: 266.1332 (M +); calc. for C14H22O3Si: 
266.1338. 
 
 
Ethyl 2-(dimethyl(4-chlorophenyl)silyl)propanoate (6) 
 
1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.3, 
1.9 Hz, 2H), 4.02 (q, J = 7.1 Hz, 2H), 2.23 (q, J = 7.1 Hz, 1H), 1.17-
1.11 (m, 6H), 0.36 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 175.87, 
135.98, 135.36, 134.75, 128.19, 60.06, 30.03, 14.45, 11.38, –4.02, –
4.61. 29Si NMR (79 MHz, CDCl3) δ 0.59. HRMS (FAB) m/z: 270.0847 
(M+); calc. for C13H19O2SiCl: 270.0843. 
 
 
Ethyl 2-(dimethyl(4-trifloromethylphenyl)silyl)propanoate (7) 
 
1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.4 Hz, 4H), 4.01 (qd, J = 
7.2, 0.7 Hz, 2H), 2.27 (q, J = 7.2 Hz, 1H), 1.16 (d, J = 7.2 Hz, 3H), 
1.12 (t, J = 7.1 Hz, 3H), 0.40 (d, J = 1.3 Hz, 6H). 13C NMR (100 MHz, 
CDCl3) δ 141.49, 134.32, 131.52 (q, JC–F = 32.3 Hz), 124.26 (q, JC–F = 
272.2 Hz), 124.43 (q, JC–F = 3.8 Hz), 60.16, 29.96, 14.39, 11.39, –
4.18, –4.65. 29Si NMR (79 MHz, CDCl3) δ 1.01. HRMS (FAB) m/z: 
304.1119 (M+); calc. for C14H19O2SiF3: 304.1106. 
 
 
Ethyl 2-(dimethyl(4-chloromethylphenyl)silyl)propanoate (8) 
 
1H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 8.0 Hz, 2H), 7.38 (d, J = 
7.9 Hz, 2H), 4.58 (s, 2H), 4.02 (q, J = 7.1 Hz, 2H), 2.25 (q, J = 7.1 
Hz, 1H), 1.18-1.08 (m, 6H), 0.37 (d, J = 1.2 Hz, 6H). 13C NMR (100 
MHz, CDCl3) δ 175.98, 138.72, 136.92, 134.44, 128.02, 60.02, 
46.23, 30.05, 14.44, 11.41, –3.97, –4.70. 29Si NMR (79 MHz, CDCl3) 
δ 0.59. HRMS (FAB) m/z: 283.0927 ((M+H)–H2 +); calc. for 
C14H20O2SiCl: 283.0921. 
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Methyl 4-((1-ethoxy-1-oxopropan-2-yl)dimethylsilyl)benzoate (9) 
 
1H NMR (400 MHz, CDCl3) δ 8.00 (d, J = 8.3 Hz, 2H), 7.58 (d, J 
= 8.3 Hz, 2H), 4.01 (qd, J = 7.1, 0.9 Hz, 2H), 3.92 (s, 3H), 2.27 (q, 
J = 7.2 Hz, 1H), 1.19-1.05 (m, 6H), 0.39 (d, J = 1.4 Hz, 6H). 13C 
NMR (100 MHz, CDCl3) δ 175.77, 167.27, 142.78, 134.01, 
131.00, 128.64, 60.07, 52.31, 29.88, 14.44, 11.37, –4.13, –4.71. 
29Si NMR (79 MHz, CDCl3) δ 0.98. HRMS (FAB) m/z: 294.1276 
(M+); calc. for C15H22O4Si: 294.1287. 
 
 
 
Ethyl 2-((4-(dimethylcarbamoyl)phenyl)dimethylsilyl)propanoate (10) 
 
1H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 8.0 Hz, 2H), 7.39 (d, J 
= 8.0 Hz, 2H), 4.03 (q, J = 7.1 Hz, 2H), 3.11 (s, 3H), 2.97 (s, 3H), 
2.26 (q, J = 7.2 Hz, 1H), 1.20-1.10 (m, 6H), 0.37 (s, 6H). 13C 
NMR (100 MHz, CDCl3) δ 175.94, 171.59, 138.39, 137.38, 
134.01, 126.37, 60.05, 39.67, 35.45, 29.95, 14.49, 11.41, –3.92, –
4.75. HRMS (FAB) m/z: 308.1689 (M+H+); calc. for 
C16H26NO3Si: 308.1682. 
 
 
Ethyl 2-((naphthalen-2-yl)dimethylsilyl)propanoate (11) 
 
1H NMR (400 MHz, CDCl3) δ 8.00 (s, 1H), 7.87-7.80 (m, 3H), 7.57 (dd, 
J = 8.2, 0.8 Hz, 1H), 7.53-7.46 (m, 2H), 4.02 (q, J = 7.1 Hz, 2H), 2.34 (q, 
J = 7.1 Hz, 1H), 1.18 (d, J = 7.1 Hz, 3H), 1.11 (t, J = 7.1 Hz, 3H), 0.46 
(d, J = 2.0 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 176.14, 134.88, 
133.99, 133.92, 132.92, 130.03, 128.23, 127.84, 127.16, 126.70, 126.15, 
60.01, 30.18, 14.44, 11.50, –3.76, –4.71. 29Si NMR (79 MHz, CDCl3) δ 
0.76. HRMS (FAB) m/z: 286.1395 (M+); calc. for C17H22O2Si: 286.1389. 
 
 
Ethyl 2-((benzofuran-2-yl)dimethylsilyl)propanoate (12) 
 
1H NMR (400 MHz, CDCl3) δ 7.58 (ddd, J = 7.7, 1.3, 0.7 Hz, 1H), 7.50 
(dd, J = 8.2, 0.9 Hz, 1H), 7.29 (ddd, J = 8.4, 7.2, 1.4 Hz, 1H), 7.21 
(ddd, J = 8.2, 7.8, 1.0 Hz, 1H), 7.05 (d, J = 1.0 Hz, 1H), 4.07 (qd, J = 
7.2, 1.2 Hz, 2H), 2.38 (q, J = 7.2 Hz, 1H), 1.24 (d, J = 7.1 Hz, 3H), 
1.14 (t, J = 7.1 Hz, 3H), 0.44 (d, J = 1.9 Hz, 6H). 13C NMR (100 MHz, 
CDCl3) δ 175.57, 159.85, 158.31, 127.82, 124.84, 122.58, 121.29, 
117.93, 111.48, 60.22, 29.42, 14.42, 11.24, –4.32, –5.05. 29Si NMR (79 
MHz, CDCl3) δ –5.09. HRMS (FAB) m/z: 276.1182 (M+); calc. for C15H20O3Si: 
276.1169. 
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Ethyl 2-(benzothiophen-2-yldimethylsilyl)propanoate (13) 
 
1H NMR (400 MHz, CDCl3) δ 7.93-7.85 (m, 1H), 7.85-7.79 (m, 1H), 
7.52 (d, J = 0.8 Hz, 1H), 7.39-7.30 (m, 2H), 4.08 (qd, J = 7.1, 1.1 Hz, 
2H), 2.33 (q, J = 7.2 Hz, 1H), 1.24 (d, J = 7.2 Hz, 3H), 1.17 (t, J = 7.1 
Hz, 3H), 0.47 (d, J = 0.9 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 
175.61, 143.84, 140.93, 137.78, 132.56, 124.64, 124.25, 123.75, 
122.30, 60.24, 30.46, 14.47, 11.43, –2.77, –3.64. 29Si NMR (79 MHz, 
CDCl3) δ –1.51. HRMS (FAB) m/z: 292.0963 (M+); calc. for C15H20O2SiS: 292.0953. 
 
 
Ethyl 2-(benzyldimethylsilyl)propanoate (14) 
 
1H NMR (400 MHz, CDCl3) δ 7.25-7.17 (m, 2H), 7.11-7.06 (m, 1H), 7.06-
6.96 (m, 2H), 4.24-4.02 (m, 2H), 2.24-2.14 (m, 2H), 2.10 (q, J = 7.1 Hz, 
1H), 1.26 (t, J = 7.1 Hz, 3H), 1.19 (d, J = 7.1 Hz, 3H), 0.06- –0.12 (m, J = 
0.5 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 176.19, 139.25, 128.44, 
128.42, 124.44, 60.04, 28.95, 24.03, 14.66, 11.17, –4.76, –4.82. 29Si NMR 
(79 MHz, CDCl3) δ 5.96. HRMS (FAB) m/z: 251.1459 (M+H+); calc. for 
C14H23O2Si: 251.1467. 
 
 
Ethyl 2-(cyclohexa-2,5-dien-1-yldimethylsilyl)propanoate (15) 
 
1H NMR (400 MHz, CDCl3) δ 5.81-5.52 (m, 4H), 4.17-4.05 (m, 2H), 2.81-
2.56 (m, 2H), 2.48-2.36 (m, 1H), 2.19 (q, J = 7.1 Hz, 1H), 1.24 (t, J = 7.1 
Hz, 3H), 1.21 (d, J = 7.2 Hz, 3H), 0.08 (d, J = 4.4 Hz, 6H). 13C NMR (100 
MHz, CDCl3) δ 176.24, 125.63, 125.53, 122.65, 122.52, 60.05, 29.47, 
28.28, 26.52, 14.59, 11.33, –6.35, –6.70. HRMS (FAB) m/z: 237.1313 
((M+H)–H2+); calc. for C13H21O2Si: 237.1311. 
 
 
Ethyl 2-((4-ethynylphenyl)dimethylsilyl)butanoate (16) 
 
1H NMR (400 MHz, CDCl3) δ 7.53-7.42 (m, 4H), 4.13-3.93 (m, 
2H), 3.11 (s, 1H), 2.08 (dd, J = 11.7, 3.1 Hz, 1H), 1.78 (ddq, J = 
14.2, 11.7, 7.1 Hz, 1H), 1.40 (dqd, J = 13.8, 7.3, 3.1 Hz, 1H), 1.13 
(t, J = 7.1 Hz, 3H), 0.89 (t, J = 7.2 Hz, 3H), 0.35 (d, J = 4.1 Hz, 
6H). 13C NMR (100 MHz, CDCl3) δ 175.05, 137.86, 133.87, 
131.36, 123.17, 83.71, 78.06, 59.95, 39.53, 20.60, 15.13, 14.47, –
3.96, –4.56. HRMS (FAB) m/z: 273.1316 ((M+H)–H2+); calc. for 
C16H21O2Si: 273.1311. 
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Isopropyl 2-((4-ethynylphenyl)dimethylsilyl)propanoate (17) 
 
1H NMR (400 MHz, CDCl3) δ 7.47 (app s, 4H), 4.91 (hept, J = 6.3 
Hz, 1H), 3.11 (s, 1H), 2.21 (q, J = 7.1 Hz, 1H), 1.16 (d, J = 6.3 Hz, 
3H), 1.13 (d, J = 7.2 Hz, 3H), 1.08 (d, J = 6.3 Hz, 3H), 0.36 (d, J = 3.0 
Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 175.39, 137.82, 133.93, 
131.36, 123.15, 83.73, 78.03, 67.33, 30.02, 22.16, 22.01, 11.45, –3.95, 
–4.69. HRMS (FAB) m/z: 275.1479 (M+H+); calc. for C16H23O2Si: 
275.1467. 
 
 
Ethyl 2-((3,4-dihydro-2H-pyran-6-yl)dimethylsilyl)propanoate (18) 
 
1H NMR (400 MHz, CDCl3) δ 5.02 (t, J = 3.8, 1H), 4.16-4.02 (m, 2H), 3.90 
(dd, J=5.8, 4.9 Hz, 2H), 2.17 (q, J = 7.1 Hz, 1H), 2.05-1.98 (m, 2H), 1.87-
1.78 (m, 2H), 1.23 (t, J = 7.1 Hz, 3H), 1.18 (d, J = 7.1 Hz, 3H), 0.14 (d, J = 
8.6 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 176.26, 157.26, 112.83, 65.77, 
59.91, 28.78, 22.79, 20.90, 14.61, 11.24, –4.96, –5.98. 29Si NMR (79 MHz, 
CDCl3) δ –4.02. HRMS (FAB) m/z: 243.1410 (M+H+); calc. for 
C12H23O3Si: 243.1417. 
 
 
Ethyl 2-((4-vinylphenyl)dimethylsilyl)propanoate (19) 
 
1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 8.1 Hz, 2H), 7.40 (d, J = 
8.0 Hz, 2H), 6.71 (dd, J = 17.6, 10.9 Hz, 1H), 5.79 (dd, J = 17.6, 0.9 
Hz, 1H), 5.27 (dd, J = 10.9, 1.0 Hz, 1H), 4.03 (q, J = 7.1 Hz, 2H), 2.25 
(q, J = 7.1 Hz, 1H), 1.16-1.13 (m, 6H), 0.37 (s, 6H). 13C NMR (100 
MHz, CDCl3) δ 176.09, 138.68, 136.85, 136.00, 134.26, 125.69, 
114.65, 59.99, 30.14, 14.46, 11.42, –3.87, –4.75. 29Si NMR (79 MHz, 
CDCl3) δ 0.26. HRMS (FAB) m/z: 262.1384 (M+); calc. for C15H22O2Si: 262.1389. 
 
 
Ethyl 2-((4-ethynylphenyl)dimethylsilyl)propanoate (20) 
 
1H NMR (400 MHz, CDCl3) δ 7.50-7.44 (m, 4H), 4.01 (qd, J = 7.2, 
0.6 Hz, 2H), 3.11 (s, 1H), 2.24 (q, J = 7.1 Hz, 1H), 1.17-1.10 (m, 6H), 
0.37 (d, J = 0.7 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 175.89, 
137.69, 133.87, 131.36, 123.20, 83.70, 78.08, 60.04, 29.98, 14.44, 
11.38, –4.10, –4.75. 29Si NMR (79 MHz, CDCl3) δ 0.79. HRMS 
(FAB) m/z: 259.1153 ((M+H)–H2+); calc. for C15H19O2Si: 259.1154. 
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Ethyl 2-((4-(benzyloxy)phenyl)dimethylsilyl)propanoate (21a) 
 
1H NMR (400 MHz, CDCl3) δ 7.46-7.30 (m, 7H), 7.05-6.93 (m, 2H), 
5.08 (s, 2H), 4.02 (q, J = 7.1 Hz, 2H), 2.22 (q, J = 7.1 Hz, 1H), 1.20-
1.10 (m, 6H), 0.35 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 176.22, 
160.07, 137.01, 135.51, 128.74, 128.13, 127.61, 127.52, 114.56, 
69.87, 59.93, 30.35, 14.48, 11.45, –3.75, –4.57. HRMS (FAB) m/z: 
342.1665 (M+); calc. for C20H26O3Si: 342.1651. 
 
 
Ethyl 2-((4-hydroxyphenyl)dimethylsilyl)propanoate (21) 
 
1H NMR (400 MHz, CDCl3) δ 7.36 (d, J = 8.5 Hz, 2H), 6.81 (d, J = 
8.6 Hz, 2H), 5.49 (s, 1H), 4.03 (qd, J = 7.1, 0.6 Hz, 2H), 2.23 (q, J = 
7.1 Hz, 1H), 1.19-1.12 (m, 6H), 0.35 (d, J = 1.2 Hz, 6H). 13C NMR 
(100 MHz, CDCl3) δ 176.67, 157.18, 135.68, 126.90, 115.16, 60.12, 
30.51, 14.46, 11.43, –3.83, –4.33. HRMS (FAB) m/z: 252.1175 (M+); 
calc. for C13H20O3Si: 252.1182. 
 
 
Ethyl 2-((4-(((benzyloxy)carbonyl)amino)phenyl)dimethylsilyl)propanoate (22a) 
 
1H NMR (400 MHz, CDCl3) δ 7.49-7.30 (m, 9H), 6.70 (s, 1H), 
5.20 (s, 2H), 4.02 (q, J = 7.1 Hz, 2H), 2.22 (q, J = 7.1 Hz, 1H), 
1.18-1.10 (m, 6H), 0.35 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 
176.13, 153.24, 139.07, 136.06, 134.98, 130.78, 128.78, 128.56, 
128.48, 117.96, 67.24, 59.98, 30.21, 14.49, 11.41, –3.83, –4.68. 
HRMS (FAB) m/z: 385.1710 (M+); calc. for C21H27NO4Si: 
385.1709. 
 
 
Ethyl 2-((4-aminophenyl)dimethylsilyl)propanoate (22) 
 
1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 8.4 Hz, 2H), 6.70 (d, J = 
8.4 Hz, 2H), 4.03 (q, J = 7.1 Hz, 2H), 3.64 (br s, 2H), 2.20 (q, J = 7.1 
Hz, 1H), 1.16 (t, J = 7.1 Hz, 3H), 1.13 (d, J = 7.1 Hz, 3H), 0.32 (s, 
6H). 13C NMR (100 MHz, CDCl3) δ 176.40, 147.40, 135.32, 124.37, 
114.82, 59.87, 30.47, 14.48, 11.44, –3.68, –4.68. HRMS (FAB) m/z: 
251.1339 (M+); calc. for C13H21NO2Si: 251.1342. [aD]25 = +46.1 (c 
0.505 in cyclohexane, 98% ee). 
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VI. Preparative-Scale Whole-Cell Biocatalytic Reaction 
 
 
 
HBamp/chlor (50 mL) in a 250 mL flask was inoculated with an overnight culture (1 
mL, LBamp/chlor) of recombinant E. cloni® EXPRESS BL21(DE3) cells containing a 
pET22(b)+ plasmid encoding Rma cyt c V75T M100D M103D, and the pEC86 plasmid. 
The culture was shaken at 37 °C and 250 rpm (no humidity control) until the OD600 was 
0.6 (approximately 2 hours). The culture was placed on ice for 30 minutes, and IPTG and 
5-ALA were added to final concentrations of 20 μM and 200 μM respectively. The 
incubator temperature was reduced to 20 °C, and the culture was allowed to shake for 20 
hours at 140 rpm. Cells were pelleted by centrifugation (4 °C, 5 min, 4,000xg), 
resuspended in M9-N buffer and adjusted to OD600 = 15. Under anaerobic conditions, to a 
5 mL reaction vial was added 960 μL whole-cell solution, 40 μL glucose solution (250 
mM in M9-N buffer), 15.8 μL 4-(dimethylsilyl)aniline (23, 0.1 mmol) and 4.9 μL Me-
EDA (0.04 mmol) at room temperature. The reaction was shaken at 480 rpm. At 4 h 
intervals, two additional batches of whole cell (960 μL), glucose (40 μL) and Me-EDA 
(4.9 μL, 0.04 mmol) were added to the reaction. After the reaction was shaken for a total 
of 20 hours, the reaction mixture was divided between four 2 mL microcentrifuge tubes, 
and 0.6 mL EtOAc was added to each tube. The reaction mixtures were subjected to 
vortex (30 seconds) and centrifugation (14,000 rpm, 7 min) to completely separate the 
organic and aqueous layers. After removal of the organic layers, two addition rounds of 
extraction were carried out. The combined organic layers were dried over anhydrous 
Na2SO4, concentrated, and purified by silica column chromatography with EtOAc / 
hexane (1:4 to 1:2) to afford pure organosilicon product 22 (17.6 mg, 0.0700 mmol, 70% 
yield), together with recovered silane 23 (4.0 mg, 0.0265 mmol, 26.5%). The 
stereoselectivity of the product was determined as 98% ee by chiral SFC. The protein 
concentration of OD600 = 15 whole-cell solution was determined to be 7.43 μM by the 
ferrous assay after cell lysis by sonication. The total turnover number for this reaction 
was 3410. 
  
E. coli
Si
OEt
O
H
NH2
Si
N
H
H
H
Me-EDA+
expressing Rma cyt c V75T M100D M103E
(0.12 mmol)
glucose, M9-N buffer (pH 7.4), room temperature
23
22
(0.1 mmol)
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VII. GC Standard Curves for Organosilicon Products  
 
The analysis of product formation in enzymatic reactions was performed based on GC 
standard curves. The general procedure for preparing analytical samples for GC standard 
curves is described below:  
 
Sample preparation for GC standard curves  
Stock solutions of chemically synthesized organosilicon products at various 
concentrations (20 to 200 mM in MeCN) were prepared. To a microcentrifuge tube were 
added 340 μL M9-N buffer, 40 μL Na2S2O4 (100 mM in dH2O), 20 μL organosilicon 
product, 20 μL internal standard (20 mM 2-phenylethanol in cyclohexane) and 1 mL 
cyclohexane. The mixture was vortexed (10 seconds, 3 times) then centrifuged 
(14,000xg, 5 min) to completely separate the organic and aqueous layers. The organic 
layer (750 μL) was removed for GC analysis. All data points represent the average of 
duplicate runs. The standard curves plot product concentration in mM (y-axis) against the 
ratio of product area to internal standard area on the GC (x-axis).  
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VIII. Chiral SFC Traces for Racemic and Enzymatically Synthesized Organosilicon 
Products  
 
All the ee values of enzymatically synthesized organosilicon products were 
determined using chiral SFC. The chiral SFC traces for racemic and enzymatic products 
are shown below.  
The absolute configuration of enzymatically synthesized organosilicon product 3 
was determined to be (R) by comparing the HPLC retention times of rac-3 and 3 with 
that reported in the literature (12). The absolute configurations of other organosilicon 
products were inferred by analogy, assuming the facial selectivity of the diazo reagents 
remains the same in the biosyntheses of compound 3-22.      
 
 
 
 
Chiralpak IC, 3% i-PrOH in CO2, 3.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-3:  
rac-3 R-3 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.224 842.723 50.03 2.172 753.160 100.00 
2.390 841.657 49.97 - -  
Total 1684.380 100.00 Total 753.160 100.00 
 
  
Si
OEt
O
H
rac or R-3
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Chiralpak AD-H, 3% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-4:  
rac-4 R-4 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.097 124486 45.44 2.142 16934.0 100.00 
2.390 149493 54.56 - -  
Total 273979 100.00 Total 16934.0 100.00 
 
  
Si
OEt
O
H
rac or R-4
Me
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Chiralpak IC, 3% i-PrOH in CO2, 3.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-5:  
rac-5 R-5 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
3.869 8651.07 49.14 3.873 1422.48 100.00 
4.349 8955.03 50.86 - -  
Total 17606.10 100.00 Total 1422.48 100.00 
 
  
Si
OEt
O
H
rac or R-5
OMe
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Chiralpak AD-H, 3% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-6:  
rac-6 R-6 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.510 4898.62 49.48 2.477 455.973 100.00 
2.746 5001.36 50.52 - -  
Total 9899.98 100.00 Total 455.973 100.00 
 
  
Si
OEt
O
H
rac or R-6
Cl
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Chiralcel OD-H, 2% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-7:  
rac-7 R-7 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.186 3895.65 49.54 2.182 1738.84 99.61 
2.431 3967.58 50.46 2.402 6.80 0.39 
Total 7863.23 100.00 Total 1745.65 100.00 
 
  
Si
OEt
O
H
rac or R-7
CF3
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Chiralpak AD-H, 3% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-8:  
rac-8 R-8 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
3.406 1698.74 49.77 3.409 2377.97 99.58 
3.914 1714.41 50.23 3.912 10.15 0.42 
Total 3413.15 100.00 Total 2388.12 100.00 
 
  
Si
OEt
O
H
rac or R-8
Cl
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Chiralcel OD-H, 5% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-9:  
rac-9 R-9 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
3.517 1773.21 50.00 3.507 582.064 100.00 
3.824 1772.88 50.00 - -  
Total 3546.09 100.00 Total 582.064 100.00 
 
  
Si
OEt
O
H
rac or R-9
O
OMe
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Chiralpak IC, 30% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-10:  
rac-10 R-10 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
6.693 2779.93 49.38 6.665 987.666 99.63 
7.000 2849.58 50.62 7.005 3.594 0.36 
Total 5629.50 100.00 Total 991.260 100.00 
 
  
Si
OEt
O
H
rac or R-10
O
N
Me
Me
 
 
50 
 
 
 
 
Chiralpak IC, 7% i-PrOH in CO2, 3.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-11:  
rac-11 R-11 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.735 8677.04 47.45 2.760 3675.15 97.51 
3.183 9609.04 52.55 3.215 93.95 2.49 
Total 18286.1 100.00 Total 3769.10 100.00 
 
  
Si
OEt
O
H
rac or R-11
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Chiralpak IC, 3% i-PrOH in CO2, 3.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-12:  
rac-12 R-12 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
3.101 7145.58 49.41 3.034 1490.62 99.16 
3.624 7315.99 50.59 3.549 12.69 0.84 
Total 14461.6 100.00 Total 1503.31 100.00 
 
  
Si
OEt
O
H
rac or R-12
O
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Chiralpak IC, 7% i-PrOH in CO2, 3.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-13:  
rac-13 R-13 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.751 7136.78 48.49 2.764 801.009 98.78 
3.209 7581.08 51.51 3.219 9.889 1.22 
Total 14717.9 100.00 Total 810.898 100.00 
 
  
Si
OEt
O
H
rac or R-13
S
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Chiralpak AD-H, 3% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-14:  
rac-14 R-14 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.142 1384.73 49.85 2.191 1991.26 99.62 
2.351 1393.07 50.15 2.402 7.58 0.38 
Total 2777.80 100.00 Total 1998.84 100.00 
 
  
Si
OEt
O
H
rac or R-14
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Chiralpak IC, 3% i-PrOH in CO2, 3.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-15:  
rac-15 R-15 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.356 361.685 50.30 2.426 390.115 99.45 
2.500 357.384 49.70 2.556 2.125 0.54 
Total 719.070 100.00 Total 392.240 100.00 
 
  
Si
OEt
O
H
rac or R-15
 
 
55 
 
 
 
 
Chiralpak AD-H, 3% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-16:  
rac-16 R-16 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.602 4276.04 49.44 2.607 2426.65 100.00 
3.526 4373.23 50.56    
Total 8649.28 100.00 Total 2426.65 100.00 
 
  
Si
OEt
O
H
rac or R-16
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Chiralpak IC, 3% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-17:  
rac-17 R-17 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
3.808 1442.74 49.78 3.829 2089.15 100.00 
4.074 1455.49 50.22    
Total 2898.23 100.00 Total 2089.15 100.00 
 
  
Si
OiPr
O
H
rac or R-17
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Chiralpak IC, 3% i-PrOH in CO2, 3.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-18:  
rac-18 R-18 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.680 1366.02 50.54 2.628 813.657 99.63 
2.887 1336.57 49.46 2.922 2.984 0.37 
Total 2702.59 100.00 Total 816.641 100.00 
 
  
Si O
OEt
O
H
rac or R-18
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Chiralpak IC, 3% i-PrOH in CO2, 3.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-19:  
rac-19 R-19 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
2.791 6332.09 49.69 2.758 1559.90 99.13 
3.001 6411.17 50.31 2.972 13.65 0.87 
Total 12743.3 100.00 Total 1573.56 100.00 
 
  
Si
OEt
O
H
rac or R-19
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Chiralcel OD-H, 3% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-20:  
rac-20 R-20 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
3.410 13436.2 48.40 3.406 1894.53 99.84 
3.774 14326.4 51.60 3.715 2.97 0.16 
Total 27762.6 100.00 Total 1897.50 100.00 
 
  
Si
OEt
O
H
rac or R-20
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Chiralpak IC, 10% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for R-21:  
rac-21 R-21 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
3.853 664.781 50.19 3.883 3332.68 99.58 
4.264 659.660 49.81 4.331 13.94 0.42 
Total 1324.441 100.00 Total 3346.62 100.00 
 
  
Si
OEt
O
H
rac or R-21
OH
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Chiralpak AD-H, 10% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac and R-22:  
rac-22 R-22 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
Retention 
Time (min) 
Area 
(mAU*s) Area % 
5.162 9214.41 48.50 - -  
5.617 9783.58 51.50 5.638 195.47 100.00 
Total 18998.0 100.00 Total 195.47 100.00 
 
Preparative-scale reaction (0.1 mmol): 
 
 
Area% report for R-22:  
R-22 (OD 15-whole cell) 
Retention Time (min) Area (mAU*s) Area % 
5.537 45.97 1.15 
5.990 3935.62 98.85 
Total 3981.59 100.00 
Si
OEt
O
H
rac or R-22
NH2
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standard. This internal standard contained a small amount of impurity, which appeared at 
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